Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy
The impact of uncommon etiology cardiomyopathies on Left-ventricular assist device (LVAD)-recipient outcomes is not very well known. This study aimed to characterize patients with uncommon cardiomyopathy etiologies and examine the outcomes between uncommon and ischemic/idiopathic dilated cardiomyopa...
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2020-05, Vol.125 (9), p.1421-1428 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1428 |
|---|---|
| container_issue | 9 |
| container_start_page | 1421 |
| container_title | The American journal of cardiology |
| container_volume | 125 |
| creator | Galand, Vincent Flécher, Erwan Chabanne, Céline Lelong, Bernard Goéminne, Céline Vincentelli, André Delmas, Clément Dambrin, Camille Picard, François Sacher, Frédéric Kindo, Michel Minh, Tam Hoang Gaudard, Philippe Rouvière, Philippe Sénage, Thomas Michel, Magali Boignard, Aude Chavanon, Olivier Verdonk, Constance Ghodhbane, Walid Pelcé, Edeline Gariboldi, Vlad Pozzi, Matteo Obadia, Jean-François Litzler, Pierre-Yvesl Anselme, Frédéric Babatasi, Gerard Blanchart, Katrien Garnier, Fabien Bielefeld, Marie Hamon, David Lellouche, Nicolas Bourguignon, Thierry Genet, Thibaud Eschalier, Romain D'Ostrevy, Nicolas Varlet, Emilie Jouan, Jérôme Vanhuyse, Fabrice Blangy, Hugues Leclercq, Christophe Martins, Raphaël P. |
| description | The impact of uncommon etiology cardiomyopathies on Left-ventricular assist device (LVAD)-recipient outcomes is not very well known. This study aimed to characterize patients with uncommon cardiomyopathy etiologies and examine the outcomes between uncommon and ischemic/idiopathic dilated cardiomyopathy. This observational study was conducted in 19 centers between 2006 and 2016. Baseline characteristics and outcomes of patients with uncommon etiology were compared to patients with idiopathic dilated/ischemic cardiomyopathies. Among 652 LVAD-recipients included, a total of 590 (90.5%) patients were classified as ischemic/idiopathic and 62 (9.5%) patients were classified in the “uncommon etiologies” group. Main uncommon etiologies were: hypertrophic (n = 12(19%)); cancer therapeutics–related cardiac dysfunction (CTRCD) (n = 12(19%)); myocarditis (n = 11(18%)); valvulopathy (n = 9(15%)) and others (n = 18(29%)). Patients with uncommon etiologies were significantly younger with more female and presented less co-morbidities. Additionally, patients with uncommon cardiomyopathies were less implanted as destination therapy compared with ischemic/idiopathic group (29% vs 38.8%). During a follow-up period of 9.1 months, both groups experienced similar survival. However, subgroup of hypertrophic/valvular cardiomyopathies and CTRCD had significantly higher mortality compared to the ischemic/idiopathic or myocarditis/others cardiomyopathies. Conversely, patients with myocarditis/others etiologies experienced a better survival. Indeed, the 12-months survival in the myocarditis/others; ischemic/idiopathic and hypertrophic/CTRCD/valvulopathy group were 77%; 65%, and 46% respectively. In conclusion, LVAD-recipients with hypertrophic cardiomyopathy, valvular heart disease and CTRCD experienced the higher mortality rate. |
| doi_str_mv | 10.1016/j.amjcard.2020.01.042 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02502716v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914920301077</els_id><sourcerecordid>2417035763</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-8e389edc8ce65507b0ef749af580592840761869cd7af8d33e5bc79ae6eb18923</originalsourceid><addsrcrecordid>eNqFkU1v0zAYxy3ExLrBRwBZ4rIdEmwnju0TqspgkyqNA4Oj5TpPqKMkLrZTqd8eVy07cNnJL8_v-T8vf4TeU1JSQptPfWnG3prQlowwUhJakpq9QgsqhSqootVrtCCEsELRWl2iqxj7_KSUN2_QZcVozaXiC-Qe52T9CBH7Dq-hS_gnTCk4Ow8m4GWMLib8BfbOAn4Yd4OZkknOT9hN-Hu-ZTjiXy5t8dOUdcYcucvxwf8-4FXuzvnx4HcmbQ9v0UVnhgjvzuc1evp692N1X6wfvz2sluvC1qJOhYRKKmittNBwTsSGQCdqZTouCVdM1kQ0VDbKtsJ0sq0q4BsrlIEGNlQqVl2j25Pu1gx6F9xowkF74_T9cq2Pf4RxwgRt9jSzNyd2F_yfGWLSo4sWhjwm-DlqVoncQyOUyOjH_9Dez2HKk2hWU0EqLpoqU_xE2eBjDNA9d0CJPvqme332TR9904Tq7FvO-3BWnzcjtM9Z_4zKwOcTAHl1ewdBR5uXb6F1AWzSrXcvlPgLnOurGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417035763</pqid></control><display><type>article</type><title>Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy</title><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Galand, Vincent ; Flécher, Erwan ; Chabanne, Céline ; Lelong, Bernard ; Goéminne, Céline ; Vincentelli, André ; Delmas, Clément ; Dambrin, Camille ; Picard, François ; Sacher, Frédéric ; Kindo, Michel ; Minh, Tam Hoang ; Gaudard, Philippe ; Rouvière, Philippe ; Sénage, Thomas ; Michel, Magali ; Boignard, Aude ; Chavanon, Olivier ; Verdonk, Constance ; Ghodhbane, Walid ; Pelcé, Edeline ; Gariboldi, Vlad ; Pozzi, Matteo ; Obadia, Jean-François ; Litzler, Pierre-Yvesl ; Anselme, Frédéric ; Babatasi, Gerard ; Blanchart, Katrien ; Garnier, Fabien ; Bielefeld, Marie ; Hamon, David ; Lellouche, Nicolas ; Bourguignon, Thierry ; Genet, Thibaud ; Eschalier, Romain ; D'Ostrevy, Nicolas ; Varlet, Emilie ; Jouan, Jérôme ; Vanhuyse, Fabrice ; Blangy, Hugues ; Leclercq, Christophe ; Martins, Raphaël P.</creator><creatorcontrib>Galand, Vincent ; Flécher, Erwan ; Chabanne, Céline ; Lelong, Bernard ; Goéminne, Céline ; Vincentelli, André ; Delmas, Clément ; Dambrin, Camille ; Picard, François ; Sacher, Frédéric ; Kindo, Michel ; Minh, Tam Hoang ; Gaudard, Philippe ; Rouvière, Philippe ; Sénage, Thomas ; Michel, Magali ; Boignard, Aude ; Chavanon, Olivier ; Verdonk, Constance ; Ghodhbane, Walid ; Pelcé, Edeline ; Gariboldi, Vlad ; Pozzi, Matteo ; Obadia, Jean-François ; Litzler, Pierre-Yvesl ; Anselme, Frédéric ; Babatasi, Gerard ; Blanchart, Katrien ; Garnier, Fabien ; Bielefeld, Marie ; Hamon, David ; Lellouche, Nicolas ; Bourguignon, Thierry ; Genet, Thibaud ; Eschalier, Romain ; D'Ostrevy, Nicolas ; Varlet, Emilie ; Jouan, Jérôme ; Vanhuyse, Fabrice ; Blangy, Hugues ; Leclercq, Christophe ; Martins, Raphaël P.</creatorcontrib><description>The impact of uncommon etiology cardiomyopathies on Left-ventricular assist device (LVAD)-recipient outcomes is not very well known. This study aimed to characterize patients with uncommon cardiomyopathy etiologies and examine the outcomes between uncommon and ischemic/idiopathic dilated cardiomyopathy. This observational study was conducted in 19 centers between 2006 and 2016. Baseline characteristics and outcomes of patients with uncommon etiology were compared to patients with idiopathic dilated/ischemic cardiomyopathies. Among 652 LVAD-recipients included, a total of 590 (90.5%) patients were classified as ischemic/idiopathic and 62 (9.5%) patients were classified in the “uncommon etiologies” group. Main uncommon etiologies were: hypertrophic (n = 12(19%)); cancer therapeutics–related cardiac dysfunction (CTRCD) (n = 12(19%)); myocarditis (n = 11(18%)); valvulopathy (n = 9(15%)) and others (n = 18(29%)). Patients with uncommon etiologies were significantly younger with more female and presented less co-morbidities. Additionally, patients with uncommon cardiomyopathies were less implanted as destination therapy compared with ischemic/idiopathic group (29% vs 38.8%). During a follow-up period of 9.1 months, both groups experienced similar survival. However, subgroup of hypertrophic/valvular cardiomyopathies and CTRCD had significantly higher mortality compared to the ischemic/idiopathic or myocarditis/others cardiomyopathies. Conversely, patients with myocarditis/others etiologies experienced a better survival. Indeed, the 12-months survival in the myocarditis/others; ischemic/idiopathic and hypertrophic/CTRCD/valvulopathy group were 77%; 65%, and 46% respectively. In conclusion, LVAD-recipients with hypertrophic cardiomyopathy, valvular heart disease and CTRCD experienced the higher mortality rate.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2020.01.042</identifier><identifier>PMID: 32145895</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiology and cardiovascular system ; Cardiomyopathy ; Cardiovascular disease ; Cardiovascular diseases ; Coronary artery disease ; Dilated cardiomyopathy ; Ejection fraction ; Etiology ; Heart diseases ; Heart failure ; Heart transplants ; Human health and pathology ; Implantation ; Ischemia ; Life Sciences ; Medical prognosis ; Mortality ; Myocarditis ; Neuromuscular diseases ; Patients ; Santé publique et épidémiologie ; Subgroups ; Surgery ; Survival ; Transplants & implants ; Ventricle</subject><ispartof>The American journal of cardiology, 2020-05, Vol.125 (9), p.1421-1428</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><rights>2020. Elsevier Inc.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-8e389edc8ce65507b0ef749af580592840761869cd7af8d33e5bc79ae6eb18923</citedby><cites>FETCH-LOGICAL-c474t-8e389edc8ce65507b0ef749af580592840761869cd7af8d33e5bc79ae6eb18923</cites><orcidid>0000-0003-4081-786X ; 0000-0002-2829-7198 ; 0000-0001-6550-0872 ; 0000-0002-7749-952X ; 0000-0003-1192-8704 ; 0000-0002-2130-9790 ; 0000-0001-8203-0454 ; 0000-0002-4399-5568 ; 0000-0001-9180-9128 ; 0000-0003-3183-7084</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2417035763?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32145895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02502716$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Galand, Vincent</creatorcontrib><creatorcontrib>Flécher, Erwan</creatorcontrib><creatorcontrib>Chabanne, Céline</creatorcontrib><creatorcontrib>Lelong, Bernard</creatorcontrib><creatorcontrib>Goéminne, Céline</creatorcontrib><creatorcontrib>Vincentelli, André</creatorcontrib><creatorcontrib>Delmas, Clément</creatorcontrib><creatorcontrib>Dambrin, Camille</creatorcontrib><creatorcontrib>Picard, François</creatorcontrib><creatorcontrib>Sacher, Frédéric</creatorcontrib><creatorcontrib>Kindo, Michel</creatorcontrib><creatorcontrib>Minh, Tam Hoang</creatorcontrib><creatorcontrib>Gaudard, Philippe</creatorcontrib><creatorcontrib>Rouvière, Philippe</creatorcontrib><creatorcontrib>Sénage, Thomas</creatorcontrib><creatorcontrib>Michel, Magali</creatorcontrib><creatorcontrib>Boignard, Aude</creatorcontrib><creatorcontrib>Chavanon, Olivier</creatorcontrib><creatorcontrib>Verdonk, Constance</creatorcontrib><creatorcontrib>Ghodhbane, Walid</creatorcontrib><creatorcontrib>Pelcé, Edeline</creatorcontrib><creatorcontrib>Gariboldi, Vlad</creatorcontrib><creatorcontrib>Pozzi, Matteo</creatorcontrib><creatorcontrib>Obadia, Jean-François</creatorcontrib><creatorcontrib>Litzler, Pierre-Yvesl</creatorcontrib><creatorcontrib>Anselme, Frédéric</creatorcontrib><creatorcontrib>Babatasi, Gerard</creatorcontrib><creatorcontrib>Blanchart, Katrien</creatorcontrib><creatorcontrib>Garnier, Fabien</creatorcontrib><creatorcontrib>Bielefeld, Marie</creatorcontrib><creatorcontrib>Hamon, David</creatorcontrib><creatorcontrib>Lellouche, Nicolas</creatorcontrib><creatorcontrib>Bourguignon, Thierry</creatorcontrib><creatorcontrib>Genet, Thibaud</creatorcontrib><creatorcontrib>Eschalier, Romain</creatorcontrib><creatorcontrib>D'Ostrevy, Nicolas</creatorcontrib><creatorcontrib>Varlet, Emilie</creatorcontrib><creatorcontrib>Jouan, Jérôme</creatorcontrib><creatorcontrib>Vanhuyse, Fabrice</creatorcontrib><creatorcontrib>Blangy, Hugues</creatorcontrib><creatorcontrib>Leclercq, Christophe</creatorcontrib><creatorcontrib>Martins, Raphaël P.</creatorcontrib><title>Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>The impact of uncommon etiology cardiomyopathies on Left-ventricular assist device (LVAD)-recipient outcomes is not very well known. This study aimed to characterize patients with uncommon cardiomyopathy etiologies and examine the outcomes between uncommon and ischemic/idiopathic dilated cardiomyopathy. This observational study was conducted in 19 centers between 2006 and 2016. Baseline characteristics and outcomes of patients with uncommon etiology were compared to patients with idiopathic dilated/ischemic cardiomyopathies. Among 652 LVAD-recipients included, a total of 590 (90.5%) patients were classified as ischemic/idiopathic and 62 (9.5%) patients were classified in the “uncommon etiologies” group. Main uncommon etiologies were: hypertrophic (n = 12(19%)); cancer therapeutics–related cardiac dysfunction (CTRCD) (n = 12(19%)); myocarditis (n = 11(18%)); valvulopathy (n = 9(15%)) and others (n = 18(29%)). Patients with uncommon etiologies were significantly younger with more female and presented less co-morbidities. Additionally, patients with uncommon cardiomyopathies were less implanted as destination therapy compared with ischemic/idiopathic group (29% vs 38.8%). During a follow-up period of 9.1 months, both groups experienced similar survival. However, subgroup of hypertrophic/valvular cardiomyopathies and CTRCD had significantly higher mortality compared to the ischemic/idiopathic or myocarditis/others cardiomyopathies. Conversely, patients with myocarditis/others etiologies experienced a better survival. Indeed, the 12-months survival in the myocarditis/others; ischemic/idiopathic and hypertrophic/CTRCD/valvulopathy group were 77%; 65%, and 46% respectively. In conclusion, LVAD-recipients with hypertrophic cardiomyopathy, valvular heart disease and CTRCD experienced the higher mortality rate.</description><subject>Cardiology and cardiovascular system</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Coronary artery disease</subject><subject>Dilated cardiomyopathy</subject><subject>Ejection fraction</subject><subject>Etiology</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Heart transplants</subject><subject>Human health and pathology</subject><subject>Implantation</subject><subject>Ischemia</subject><subject>Life Sciences</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Myocarditis</subject><subject>Neuromuscular diseases</subject><subject>Patients</subject><subject>Santé publique et épidémiologie</subject><subject>Subgroups</subject><subject>Surgery</subject><subject>Survival</subject><subject>Transplants & implants</subject><subject>Ventricle</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU1v0zAYxy3ExLrBRwBZ4rIdEmwnju0TqspgkyqNA4Oj5TpPqKMkLrZTqd8eVy07cNnJL8_v-T8vf4TeU1JSQptPfWnG3prQlowwUhJakpq9QgsqhSqootVrtCCEsELRWl2iqxj7_KSUN2_QZcVozaXiC-Qe52T9CBH7Dq-hS_gnTCk4Ow8m4GWMLib8BfbOAn4Yd4OZkknOT9hN-Hu-ZTjiXy5t8dOUdcYcucvxwf8-4FXuzvnx4HcmbQ9v0UVnhgjvzuc1evp692N1X6wfvz2sluvC1qJOhYRKKmittNBwTsSGQCdqZTouCVdM1kQ0VDbKtsJ0sq0q4BsrlIEGNlQqVl2j25Pu1gx6F9xowkF74_T9cq2Pf4RxwgRt9jSzNyd2F_yfGWLSo4sWhjwm-DlqVoncQyOUyOjH_9Dez2HKk2hWU0EqLpoqU_xE2eBjDNA9d0CJPvqme332TR9904Tq7FvO-3BWnzcjtM9Z_4zKwOcTAHl1ewdBR5uXb6F1AWzSrXcvlPgLnOurGA</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Galand, Vincent</creator><creator>Flécher, Erwan</creator><creator>Chabanne, Céline</creator><creator>Lelong, Bernard</creator><creator>Goéminne, Céline</creator><creator>Vincentelli, André</creator><creator>Delmas, Clément</creator><creator>Dambrin, Camille</creator><creator>Picard, François</creator><creator>Sacher, Frédéric</creator><creator>Kindo, Michel</creator><creator>Minh, Tam Hoang</creator><creator>Gaudard, Philippe</creator><creator>Rouvière, Philippe</creator><creator>Sénage, Thomas</creator><creator>Michel, Magali</creator><creator>Boignard, Aude</creator><creator>Chavanon, Olivier</creator><creator>Verdonk, Constance</creator><creator>Ghodhbane, Walid</creator><creator>Pelcé, Edeline</creator><creator>Gariboldi, Vlad</creator><creator>Pozzi, Matteo</creator><creator>Obadia, Jean-François</creator><creator>Litzler, Pierre-Yvesl</creator><creator>Anselme, Frédéric</creator><creator>Babatasi, Gerard</creator><creator>Blanchart, Katrien</creator><creator>Garnier, Fabien</creator><creator>Bielefeld, Marie</creator><creator>Hamon, David</creator><creator>Lellouche, Nicolas</creator><creator>Bourguignon, Thierry</creator><creator>Genet, Thibaud</creator><creator>Eschalier, Romain</creator><creator>D'Ostrevy, Nicolas</creator><creator>Varlet, Emilie</creator><creator>Jouan, Jérôme</creator><creator>Vanhuyse, Fabrice</creator><creator>Blangy, Hugues</creator><creator>Leclercq, Christophe</creator><creator>Martins, Raphaël P.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0003-4081-786X</orcidid><orcidid>https://orcid.org/0000-0002-2829-7198</orcidid><orcidid>https://orcid.org/0000-0001-6550-0872</orcidid><orcidid>https://orcid.org/0000-0002-7749-952X</orcidid><orcidid>https://orcid.org/0000-0003-1192-8704</orcidid><orcidid>https://orcid.org/0000-0002-2130-9790</orcidid><orcidid>https://orcid.org/0000-0001-8203-0454</orcidid><orcidid>https://orcid.org/0000-0002-4399-5568</orcidid><orcidid>https://orcid.org/0000-0001-9180-9128</orcidid><orcidid>https://orcid.org/0000-0003-3183-7084</orcidid></search><sort><creationdate>20200501</creationdate><title>Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy</title><author>Galand, Vincent ; Flécher, Erwan ; Chabanne, Céline ; Lelong, Bernard ; Goéminne, Céline ; Vincentelli, André ; Delmas, Clément ; Dambrin, Camille ; Picard, François ; Sacher, Frédéric ; Kindo, Michel ; Minh, Tam Hoang ; Gaudard, Philippe ; Rouvière, Philippe ; Sénage, Thomas ; Michel, Magali ; Boignard, Aude ; Chavanon, Olivier ; Verdonk, Constance ; Ghodhbane, Walid ; Pelcé, Edeline ; Gariboldi, Vlad ; Pozzi, Matteo ; Obadia, Jean-François ; Litzler, Pierre-Yvesl ; Anselme, Frédéric ; Babatasi, Gerard ; Blanchart, Katrien ; Garnier, Fabien ; Bielefeld, Marie ; Hamon, David ; Lellouche, Nicolas ; Bourguignon, Thierry ; Genet, Thibaud ; Eschalier, Romain ; D'Ostrevy, Nicolas ; Varlet, Emilie ; Jouan, Jérôme ; Vanhuyse, Fabrice ; Blangy, Hugues ; Leclercq, Christophe ; Martins, Raphaël P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-8e389edc8ce65507b0ef749af580592840761869cd7af8d33e5bc79ae6eb18923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cardiology and cardiovascular system</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Coronary artery disease</topic><topic>Dilated cardiomyopathy</topic><topic>Ejection fraction</topic><topic>Etiology</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Heart transplants</topic><topic>Human health and pathology</topic><topic>Implantation</topic><topic>Ischemia</topic><topic>Life Sciences</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Myocarditis</topic><topic>Neuromuscular diseases</topic><topic>Patients</topic><topic>Santé publique et épidémiologie</topic><topic>Subgroups</topic><topic>Surgery</topic><topic>Survival</topic><topic>Transplants & implants</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galand, Vincent</creatorcontrib><creatorcontrib>Flécher, Erwan</creatorcontrib><creatorcontrib>Chabanne, Céline</creatorcontrib><creatorcontrib>Lelong, Bernard</creatorcontrib><creatorcontrib>Goéminne, Céline</creatorcontrib><creatorcontrib>Vincentelli, André</creatorcontrib><creatorcontrib>Delmas, Clément</creatorcontrib><creatorcontrib>Dambrin, Camille</creatorcontrib><creatorcontrib>Picard, François</creatorcontrib><creatorcontrib>Sacher, Frédéric</creatorcontrib><creatorcontrib>Kindo, Michel</creatorcontrib><creatorcontrib>Minh, Tam Hoang</creatorcontrib><creatorcontrib>Gaudard, Philippe</creatorcontrib><creatorcontrib>Rouvière, Philippe</creatorcontrib><creatorcontrib>Sénage, Thomas</creatorcontrib><creatorcontrib>Michel, Magali</creatorcontrib><creatorcontrib>Boignard, Aude</creatorcontrib><creatorcontrib>Chavanon, Olivier</creatorcontrib><creatorcontrib>Verdonk, Constance</creatorcontrib><creatorcontrib>Ghodhbane, Walid</creatorcontrib><creatorcontrib>Pelcé, Edeline</creatorcontrib><creatorcontrib>Gariboldi, Vlad</creatorcontrib><creatorcontrib>Pozzi, Matteo</creatorcontrib><creatorcontrib>Obadia, Jean-François</creatorcontrib><creatorcontrib>Litzler, Pierre-Yvesl</creatorcontrib><creatorcontrib>Anselme, Frédéric</creatorcontrib><creatorcontrib>Babatasi, Gerard</creatorcontrib><creatorcontrib>Blanchart, Katrien</creatorcontrib><creatorcontrib>Garnier, Fabien</creatorcontrib><creatorcontrib>Bielefeld, Marie</creatorcontrib><creatorcontrib>Hamon, David</creatorcontrib><creatorcontrib>Lellouche, Nicolas</creatorcontrib><creatorcontrib>Bourguignon, Thierry</creatorcontrib><creatorcontrib>Genet, Thibaud</creatorcontrib><creatorcontrib>Eschalier, Romain</creatorcontrib><creatorcontrib>D'Ostrevy, Nicolas</creatorcontrib><creatorcontrib>Varlet, Emilie</creatorcontrib><creatorcontrib>Jouan, Jérôme</creatorcontrib><creatorcontrib>Vanhuyse, Fabrice</creatorcontrib><creatorcontrib>Blangy, Hugues</creatorcontrib><creatorcontrib>Leclercq, Christophe</creatorcontrib><creatorcontrib>Martins, Raphaël P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galand, Vincent</au><au>Flécher, Erwan</au><au>Chabanne, Céline</au><au>Lelong, Bernard</au><au>Goéminne, Céline</au><au>Vincentelli, André</au><au>Delmas, Clément</au><au>Dambrin, Camille</au><au>Picard, François</au><au>Sacher, Frédéric</au><au>Kindo, Michel</au><au>Minh, Tam Hoang</au><au>Gaudard, Philippe</au><au>Rouvière, Philippe</au><au>Sénage, Thomas</au><au>Michel, Magali</au><au>Boignard, Aude</au><au>Chavanon, Olivier</au><au>Verdonk, Constance</au><au>Ghodhbane, Walid</au><au>Pelcé, Edeline</au><au>Gariboldi, Vlad</au><au>Pozzi, Matteo</au><au>Obadia, Jean-François</au><au>Litzler, Pierre-Yvesl</au><au>Anselme, Frédéric</au><au>Babatasi, Gerard</au><au>Blanchart, Katrien</au><au>Garnier, Fabien</au><au>Bielefeld, Marie</au><au>Hamon, David</au><au>Lellouche, Nicolas</au><au>Bourguignon, Thierry</au><au>Genet, Thibaud</au><au>Eschalier, Romain</au><au>D'Ostrevy, Nicolas</au><au>Varlet, Emilie</au><au>Jouan, Jérôme</au><au>Vanhuyse, Fabrice</au><au>Blangy, Hugues</au><au>Leclercq, Christophe</au><au>Martins, Raphaël P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>125</volume><issue>9</issue><spage>1421</spage><epage>1428</epage><pages>1421-1428</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><abstract>The impact of uncommon etiology cardiomyopathies on Left-ventricular assist device (LVAD)-recipient outcomes is not very well known. This study aimed to characterize patients with uncommon cardiomyopathy etiologies and examine the outcomes between uncommon and ischemic/idiopathic dilated cardiomyopathy. This observational study was conducted in 19 centers between 2006 and 2016. Baseline characteristics and outcomes of patients with uncommon etiology were compared to patients with idiopathic dilated/ischemic cardiomyopathies. Among 652 LVAD-recipients included, a total of 590 (90.5%) patients were classified as ischemic/idiopathic and 62 (9.5%) patients were classified in the “uncommon etiologies” group. Main uncommon etiologies were: hypertrophic (n = 12(19%)); cancer therapeutics–related cardiac dysfunction (CTRCD) (n = 12(19%)); myocarditis (n = 11(18%)); valvulopathy (n = 9(15%)) and others (n = 18(29%)). Patients with uncommon etiologies were significantly younger with more female and presented less co-morbidities. Additionally, patients with uncommon cardiomyopathies were less implanted as destination therapy compared with ischemic/idiopathic group (29% vs 38.8%). During a follow-up period of 9.1 months, both groups experienced similar survival. However, subgroup of hypertrophic/valvular cardiomyopathies and CTRCD had significantly higher mortality compared to the ischemic/idiopathic or myocarditis/others cardiomyopathies. Conversely, patients with myocarditis/others etiologies experienced a better survival. Indeed, the 12-months survival in the myocarditis/others; ischemic/idiopathic and hypertrophic/CTRCD/valvulopathy group were 77%; 65%, and 46% respectively. In conclusion, LVAD-recipients with hypertrophic cardiomyopathy, valvular heart disease and CTRCD experienced the higher mortality rate.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32145895</pmid><doi>10.1016/j.amjcard.2020.01.042</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4081-786X</orcidid><orcidid>https://orcid.org/0000-0002-2829-7198</orcidid><orcidid>https://orcid.org/0000-0001-6550-0872</orcidid><orcidid>https://orcid.org/0000-0002-7749-952X</orcidid><orcidid>https://orcid.org/0000-0003-1192-8704</orcidid><orcidid>https://orcid.org/0000-0002-2130-9790</orcidid><orcidid>https://orcid.org/0000-0001-8203-0454</orcidid><orcidid>https://orcid.org/0000-0002-4399-5568</orcidid><orcidid>https://orcid.org/0000-0001-9180-9128</orcidid><orcidid>https://orcid.org/0000-0003-3183-7084</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2020-05, Vol.125 (9), p.1421-1428 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_02502716v1 |
| source | Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Cardiology and cardiovascular system Cardiomyopathy Cardiovascular disease Cardiovascular diseases Coronary artery disease Dilated cardiomyopathy Ejection fraction Etiology Heart diseases Heart failure Heart transplants Human health and pathology Implantation Ischemia Life Sciences Medical prognosis Mortality Myocarditis Neuromuscular diseases Patients Santé publique et épidémiologie Subgroups Surgery Survival Transplants & implants Ventricle |
| title | Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A54%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20Left%20Ventricular%20Assist%20Device%20Implantation%20in%20Patients%20With%20Uncommon%20Etiology%20Cardiomyopathy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Galand,%20Vincent&rft.date=2020-05-01&rft.volume=125&rft.issue=9&rft.spage=1421&rft.epage=1428&rft.pages=1421-1428&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2020.01.042&rft_dat=%3Cproquest_hal_p%3E2417035763%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2417035763&rft_id=info:pmid/32145895&rft_els_id=S0002914920301077&rfr_iscdi=true |